Tao Xia, Chi Cheng, Yudi Meng, Hao Huang, Duo Li, Renfan Zhu et al. Factors Associated With Recurrence After Adjuvant Gemcitabine and Nab‐Paclitaxel in Patients With Resected Pancreatic Ductal Adenocarcinoma. // Cancer Medicine. – 2026. – DOI: 10.1002/cam4.72491. – URL: https://onlinelibrary.wiley.com/doi/10.1002/cam4.72491?af=R
Tao Xia, Chi Cheng, Yudi Meng, Hao Huang, Duo Li, Renfan Zhu, Chengcong Qiu, & Yongfei Hua (2026). Factors Associated With Recurrence After Adjuvant Gemcitabine and Nab‐Paclitaxel in Patients With Resected Pancreatic Ductal Adenocarcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.72491
Tao Xia, et al. “Factors Associated With Recurrence After Adjuvant Gemcitabine and Nab‐Paclitaxel in Patients With Resected Pancreatic Ductal Adenocarcinoma.” Cancer Medicine, 2026. doi:10.1002/cam4.72491.
@article{Xia2026,
title = {Factors Associated With Recurrence After Adjuvant Gemcitabine and Nab‐Paclitaxel in Patients With Resected Pancreatic Ductal Adenocarcinoma},
author = {Xia, Tao and Cheng, Chi and Meng, Yudi and Huang, Hao and Li, Duo and Zhu, Renfan and Qiu, Chengcong and Hua, Yongfei},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72491},
url = {https://onlinelibrary.wiley.com/doi/10.1002/cam4.72491?af=R}
}